Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and <i>in vitro</i> experiments

Houyu Duan; Biao Chen; Wei Wang; Hesheng Luo

doi:doi:10.18632/aging.204545

← Back

Research Paper Volume 15, Issue 5 pp 1445—1474

Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments

Figure 3. Validation of the expression levels of 23 candidate hub genes between GC and normal controls using the GEPIA2 database. |Log₂FC|: 1 and P-value: 0.01 were set as the cutoff. FC, fold change; GC, gastric cancer; GEPIA, Gene Expression Profiling Interactive Analysis. N, normal; STAD, stomach adenocarcinoma; and T, tumor.